Related Experiment Video

Updated: Aug 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Pharmacogenetics of response to statins: where do we stand?

Anke-Hilse Maitland-van der Zee1, Eric Boerwinkle

  • 1Human Genetics Center, Health Science Center at Houston, University of Texas, 1200 Hermann Pressler, Houston, TX 77030, USA.

Current Atherosclerosis Reports
|April 7, 2005
PubMed

Insights

Statin therapy lowers cardiovascular disease risk, but individual responses vary significantly. Understanding genetic factors through pharmacogenetics requires larger studies and analysis of multiple genes for better prediction.

Area of Science:

  • Pharmacogenetics
  • Cardiovascular Medicine
  • Genetics

Background:

  • Cardiovascular disease is a leading cause of mortality, particularly in developed nations.
  • Statin therapy is a widely used intervention for lowering blood cholesterol and reducing cardiovascular risk.
  • Statin therapy offers an average 27% risk reduction for coronary artery disease, but individual responses vary considerably.

Purpose of the Study:

  • To explore the role of genetic factors in interindividual variations in statin response.
  • To review existing pharmacogenetic studies on statin treatment efficacy and cardiovascular disease prevention.

Main Methods:

  • Review of 23 studies examining genetic polymorphisms at 20 loci for lipid response to statins in hypercholesterolemia.
  • Review of 18 studies investigating genetic polymorphisms related to statin benefits in cardiovascular disease prevention.

Main Results:

  • Numerous genetic polymorphisms have been investigated for their influence on statin efficacy.
  • Few of the findings from existing pharmacogenetic studies have been successfully replicated.
  • The origins of significant interindividual variation in statin response remain poorly understood.

Conclusions:

  • Larger sample sizes are essential for robust pharmacogenetic research in statin response.
  • Investigating multiple genes simultaneously is crucial for a comprehensive understanding of statin pharmacogenetics.
  • Further research is needed to elucidate the genetic underpinnings of variable statin response.

Related Concept Videos

Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...